THE SAGE GROUP Finds A Significant Number Of New Pharmaceuticals In Clinical Trials For Treatment Of Peripheral Arterial Disease

According to a report published by THE SAGE GROUP, research activity has intensified on pharmaceutical treatments for peripheral arterial disease (PAD). “Our analysis found a significant number of new oral therapies in human clinical trials for PAD,” stated Mary L. Yost, author of the report.

More: continued here

Filed under: Cardiovascular on February 19th, 2008